drugset / Trial / NCT00008554
Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy
Parallel-groupTreatment
Summary
The purpose of this study is to compare GW433908 and nelfinavir when each is given with abacavir and lamivudine to HIV patients who have not taken antiretroviral drugs.
Timeline
- Start
- 2000-11
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fosamprenavir | Small molecule | 1400 mg | — |
| Subject | Nelfinavir | Other / unclassified | 1250 mg | — |
| Background | Abacavir | Other / unclassified | — | — |
| Background | Lamivudine | Other / unclassified | — | — |